11 Best All-Time High Stocks to Buy According to Wall Street

In this article, we’ll look at the 11 Best All-Time High Stocks to Buy According to Wall Street.

When stock prices are breaking records, the instinct is often to wait for a pullback. But history suggests that hesitation can be costly. Markets reach new peaks more often than most assume, and in many cases, those highs mark continuation, not exhaustion.

J.P. Morgan Asset Management notes that “stocks can stay attractive at all-time highs,” adding that since 1950, the S&P 500 has achieved an all-time high on “roughly 7% of trading days.” In fact, “almost a third became new market floors.” Vanguard makes a similar point, observing that “stocks have performed slightly better on a forward 1-, 3-, and 5-year basis when starting from an all-time high.” In other words, record levels have historically been part of the normal upward drift of equities rather than a reliable sell signal.

BlackRock warns that “many apparent highs tend to be followed by a newer high,” and cautions that investors risk missing “significant further gains” if they treat every record as a top. Fidelity is even more direct: “Getting out can cost you,” noting that market timing is “notoriously difficult, if not impossible.”

With that backdrop, we’ll look at the 11 Best All-Time High Stocks to Buy According to Wall Street.

hidden multibagger stocks

Our Methodology

To identify the 11 Best All-Time High Stocks to Buy According to Wall Street, we used the Finviz screener to generate a list of stocks that have reached their all-time high within the past 7 days. We then used the CNN analyst ratings compilation to determine the median upside for each stock as of February 18, 2026, and ranked the 11 stocks according to their upside potential. We have also included the number of hedge funds that hold the stock as of Q3 2025.

Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 427.7% since May 2014, beating its benchmark by 264 percentage points (see more details here).

11. Ameren Corporation (NYSE:AEE)

Potential upside: 3.13%

Number of Hedge Fund Holders: 34

On February 13, 2026, Wells Fargo raised its price target on Ameren Corporation (NYSE:AEE) to $113 from $111 and maintained an Overweight rating following a slight Q4 2025 beat. Wells Fargo highlighted management’s view that EPS could eventually exceed 8% and said its current 8.4% model may prove conservative.

Also on February 13, 2026, BMO Capital raised its price target on Ameren Corporation (NYSE:AEE) to $120 from $112 and kept an Outperform rating, citing a 21% increase in the capital plan that adds about 140 basis points to rate base growth. BMO Capital said Ameren has significant visibility into upside drivers that could push results above the top end of its long-term EPS growth target. Mizuho raised its price target on Ameren Corporation (NYSE:AEE) the same day to $117 from $110 and maintained an Outperform rating.

On February 11, 2026, Ameren Corporation (NYSE:AEE) reported Q4 adjusted EPS of 78c versus consensus.

Ameren Corporation (NYSE:AEE) operates as a public utility holding company in the United States through its Ameren Missouri, Ameren Illinois Electric Distribution, Ameren Illinois Natural Gas, and Ameren Transmission segments, providing rate-regulated electric and natural gas services.

10. Ross Stores, Inc. (NASDAQ:ROST)

Potential upside: 3.43%

Number of Hedge Fund Holders: 58

On February 17, 2026, UBS raised its price target on Ross Stores, Inc. (NASDAQ:ROST) to $199 from $181 previously and maintained a Neutral rating, citing a balanced upside and downside skew heading into the fourth quarter earnings report.

On February 10, 2026, Citi analyst Paul Lejuez raised the price target on Ross Stores, Inc. (NASDAQ:ROST) to $224 from $188 previously and kept a Buy rating, modeling EPS of $2.00 and 7% comp growth, with fourth quarter results due March 3 expected to come in above consensus and guidance.

Goldman Sachs has also raised its price target on Ross Stores, Inc. (NASDAQ:ROST) to $214 from $190 previously and maintained a Buy rating, remaining constructive on the off-price sector. Goldman Sachs said the industry is structurally positioned to benefit from trade-down activity, a healthier middle-income consumer, and modest average unit retail growth tied to tariff-related pricing increases at full-price retail, and sees strong momentum for Ross Stores, Inc. (NASDAQ:ROST) into the fourth quarter.

Ross Stores, Inc. (NASDAQ:ROST) operates off-price retail apparel and home fashion stores in the United States under the Ross Dress for Less and dd’s DISCOUNTS brands.

9. Evergy, Inc. (NASDAQ:EVRG)

Potential upside: 4.28%

Number of Hedge Fund Holders: 33

On February 13, 2026, UBS analyst William Appicelli downgraded Evergy, Inc. (NASDAQ:EVRG) to Neutral from Buy and raised the price target to $88 from $86 previously. William Appicelli cited limited upside after strong regulatory performance and share price strength over the past year, noting the stock now trades at an in-line multiple that reflects 7% to 8% earnings growth, execution risks, and an improved regulatory backdrop.

On February 12, 2026, BofA raised its price target on Evergy, Inc. (NASDAQ:EVRG) to $85 from $84 and maintained a Buy rating. BofA forecasts Q4 adjusted EPS of 53c, up from 35c last year, while noting weather headwinds could keep results slightly below consensus despite solid underlying demand. On January 23, 2026, RBC Capital analyst Stephen D’Ambrisi lowered the price target on Evergy, Inc. (NASDAQ:EVRG) to $91 from $93 previously and kept an Outperform rating as part of a broader Utilities Q4 preview. Stephen D’Ambrisi said model revisions reflect updated capital plans across the sector as utilities adjust to a changing capital deployment landscape.

Evergy, Inc. (NASDAQ:EVRG) generates, transmits, distributes, and sells electricity in the United States.

8. AerCap Holdings N.V. (NYSE:AER)

Potential upside: 7.17%

Number of Hedge Fund Holders: 55

On February 10, 2026, Deutsche Bank raised its price target on AerCap Holdings N.V. (NYSE:AER) to $175 from $145 previously and maintained a Buy rating, saying the company is well positioned to benefit from a tight supply and demand backdrop.

On February 6, 2026, AerCap Holdings N.V. (NYSE:AER) reported Q4 revenue of $2.24B versus consensus of $2.12B. CEO Aengus Kelly said the company delivered “another strong quarter,” capping a year of record net income and earnings per share. Aengus Kelly noted $3.9 billion of asset sales generating record gains of $819 million, $5.4 billion of asset purchases, and 103 aircraft firm orders and options added to the order book, while returning $2.6 billion of capital to shareholders. Kelly also highlighted a new $1 billion share repurchase program announced in December and an increase in the quarterly dividend to $0.40 per share, adding that AerCap Holdings N.V. (NYSE:AER) will continue seeking attractive capital deployment opportunities in 2026.

AerCap Holdings N.V. (NYSE:AER) leases, finances, sells, and manages commercial flight equipment globally.

7. Krystal Biotech, Inc. (NASDAQ:KRYS)

Potential upside: 7.70%

Number of Hedge Fund Holders: 26

On February 17, 2026, Jefferies analyst Roger Song raised the price target on Krystal Biotech, Inc. (NASDAQ:KRYS) to $371 from $310 and maintained a Buy rating. Roger Song noted another strong quarter and full year, with Vyjuvek and DEB U.S. revenue growth re-accelerating on robust demand and penetration reaching about 60%, while ex-U.S. expansion is expected to become a 2026 growth driver. Roger Song also said the pipeline continues to mature, with two ophthalmology programs in pivotal trials with data expected in 2026 and two additional programs nearing pivotal stages.

Also on February 17, 2026, Krystal Biotech reported Q4 revenue of $107.1M versus consensus of $105.13M. Chairman and CEO Krish S. Krishnan said, “Krystal made meaningful progress” in serving patients with dystrophic epidermolysis bullosa while building global infrastructure to scale impact. Krish S. Krishnan added that a recent cystic fibrosis readout reinforces the versatility of the company’s platform and said multiple registrational study readouts are expected across the rare disease pipeline.

On February 9, 2026, Krystal Biotech announced that the U.S. Food and Drug Administration granted Regenerative Medicine Advanced Therapy designation to KB707 for the treatment of advanced or metastatic non-small cell lung cancer. The designation was supported by early clinical evidence from the ongoing KYANITE-1 study showing consistent antitumor activity, including durable responses and tumor reductions in heavily pre-treated patients.

Krystal Biotech, Inc. (NASDAQ:KRYS) is a commercial-stage biotechnology company focused on developing and commercializing genetic medicines for diseases with high unmet medical needs in the United States.

6. Nicolet Bankshares, Inc. (NYSE:NIC)

Potential upside: 7.81%

Number of Hedge Fund Holders: 12

On February 17, 2026, Nicolet Bankshares, Inc. (NYSE:NIC) completed its merger with MidWestOne Financial Group, with MidWestOne merging into Nicolet as the surviving corporation. MidWestOne Bank will operate as a division of Nicolet National Bank until a planned system conversion in August, after which more than 50 MidWestOne locations will transition to the Nicolet brand and digital banking platform, expanding the company’s footprint in Iowa, the Twin Cities, Western Wisconsin, and Denver. Based on initial financial data, the transaction adds approximately $6B in assets, bringing total assets to about $15B, with total loans increasing to approximately $11B and total deposits to approximately $13B. Chairman, President, and CEO Mike Daniels said, “The completion of this merger represents an important milestone in Nicolet’s disciplined growth strategy,” adding that the combination enhances the company’s ability to serve customers across an expanded footprint while maintaining local decision-making.

On January 27, 2026, Hovde Group raised its price target on Nicolet Bankshares to $190 from $170 and maintained an Outperform rating. On January 22, 2026, Maxim raised its price target to $173 from $161 and kept a Buy rating following a Q4 earnings beat, citing higher earning assets, a stable net interest margin of 3.86%, and continued strong credit quality.

On January 20, 2026, Nicolet Bankshares reported Q4 EPS of $2.65 versus the consensus of $2.54. Mike Daniels said, “2025 was a defining year for Nicolet,” highlighting record earnings and earnings per share while exceeding targets across key performance metrics. Mike Daniels added that record net income, net interest margin expansion, and core deposit growth reflect the strength of the company’s community bank franchise and position it well for opportunities in 2026, including welcoming MidWestOne customers and employees.

Nicolet Bankshares, Inc. (NYSE:NIC) operates as the bank holding company for Nicolet National Bank, providing banking products and services to businesses and individuals in Wisconsin, Michigan, and Minnesota.

5. FedEx Corporation (NYSE:FDX)

Potential upside: 7.91%

Number of Hedge Fund Holders: 60

On February 13, 2026, Stifel analyst J. Bruce Chan raised the price target on FedEx Corporation (NYSE:FDX) to $412 from $328 and maintained a Buy rating after the company hosted an Investor Day outlining its mid-term strategic roadmap to 2029. J. Bruce Chan said FedEx is emerging from a turbulent stretch in the parcel market, shaped by 3.5 years of freight cycle softness, the post-COVID normalization of e-commerce growth, shifting competition, and trade flow disruption tied to changing government policy. Stifel highlighted management’s commercial priorities targeting 4% compound annual revenue growth with modest macro contribution and 8% operating margins by 2029.

Also on February 13, 2026, Morgan Stanley analyst Ravi Shanker raised the price target to $220 from $210. Ravi Shanker said FedEx has largely been an idiosyncratic story since 2013, but after Network 2.0 in early 2027, growth is expected to hinge more on industry dynamics, bringing structural challenges into focus.

At its 2026 Investor Day, FedEx outlined plans to strengthen its position as a leading industrial network, prioritizing premium growth in high-margin verticals, scaling digital and AI capabilities, and transforming its network to improve profitability. The company set 2029 targets of $98B in revenue, $8B in operating income, an 8% operating margin, 11% ROIC, CapEx at 4% of revenue, and $6B in adjusted free cash flow, with a projected $3B increase in operating income driven by initiatives across its realigned reporting segments.

FedEx Corporation (NYSE:FDX) provides transportation, e-commerce, and business services globally and operates through its Federal Express and FedEx Freight segments.

4. The Williams Companies, Inc. (NYSE:WMB)

Potential upside: 8.39%

Number of Hedge Fund Holders: 73

On February 17, 2026, Jefferies raised its price target on The Williams Companies, Inc. (NYSE:WMB) to $81 from $78 and maintained a Buy rating following what Jefferies described as a “strong” analyst day update. Jefferies expects Williams to deliver a 12% to 13% EBITDA compound annual growth rate through FY30 and views the company as capable of sustaining a 10%-plus EBITDA trajectory beyond 2030.

Also on February 17, 2026, UBS raised its price target to $89 from $78 and kept a Buy rating. UBS highlighted roughly $7.3B of power generation backlog, positioning Williams as one of the best-levered midstream operators to rising natural gas demand from power generation and data centers through its Power Innovation business. UBS said the backlog is expected to generate about $1.4B in annual EBITDA by 2029, with approximately 1.9 GW of projects in execution by 2028 and a broader opportunity set of around 6 GW.

On February 10, 2026, Williams reported Q4 adjusted EPS of 55c versus the consensus of 57c. President and CEO Chad Zamarin said, “Williams delivered record Adjusted EBITDA of $7.75 billion” in 2025, reflecting a five-year Adjusted EBITDA CAGR of 9% and a five-year EPS CAGR of 14%. Chad Zamarin added that 2026 Adjusted EBITDA guidance is set at $8.2 billion at the midpoint, supported by pipeline transmission and offshore projects that came online in 202,5 and expected revenue from the first power innovation project coming online in the second half of 2026.

The Williams Companies, Inc. (NYSE:WMB) operates energy infrastructure assets in the United States through its Transmission & Gulf of America, Northeast G&P, West, and Gas & NGL Marketing Services segments.

3. SharkNinja, Inc. (NYSE:SN)

Potential upside: 10.31%

Number of Hedge Fund Holders: 71

On February 13, 2026, Oppenheimer raised its price target on SharkNinja, Inc. (NYSE:SN) to $145 from $140 and maintained an Outperform rating following meetings with management. Oppenheimer said it came away incrementally more upbeat on the company’s near- and longer-term prospects and believes the drivers remain in place for continued double-digit top- and bottom-line momentum, keeping SharkNinja as a top pick.

On February 12, 2026, Morgan Stanley analyst Megan Alexander Clapp raised their price target to $128 from $110 and kept an Equal Weight rating. Guggenheim analyst Steven Forbes raised their price target the same day to $145 from $140 and maintained a Buy rating, saying SharkNinja entered 2026 with “solid,” industry-leading operating momentum following a broad-based Q4 beat.

On February 11, 2026, SharkNinja reported Q4 revenue of $2.10B versus consensus of $2.09B. CEO Mark Barrocas said the company delivered “exceptional Q4 results,” with 17.6% net sales growth and momentum across its portfolio. He highlighted strength across all four product categories, including 63.2% growth in Beauty and Home Environment Appliances, and said adjusted gross margin improved by 40 basis points while the company continued investing in growth initiatives.

SharkNinja, Inc. (NYSE:SN) designs and markets consumer products, including cleaning, cooking, beverage, and home environment appliances globally.

2. The Chefs’ Warehouse, Inc. (NASDAQ:CHEF)

Potential upside: 11.73%

Number of Hedge Fund Holders: 33

On February 11, 2026, The Chefs’ Warehouse, Inc. (NASDAQ:CHEF) reported Q4 revenue of $1.14B versus consensus of $1.1B. Chairman and Chief Executive Officer Christopher Pappas said “business activity and demand remained consistently strong through the fourth quarter,” citing a healthy environment for the upscale-casual to higher-end dining customer base and strong execution across domestic and international markets during the holiday season. Christopher Pappas added that the company continued to grow market share, ending the year with year-over-year organic volume growth, unique item placements, and new customer acquisition.

The Chefs’ Warehouse, Inc. (NASDAQ:CHEF) sees FY26 revenue of $4.35B to $4.45B versus consensus of $4.4B.

On January 29, 2026, Benchmark raised its price target on The Chefs’ Warehouse, Inc. (NASDAQ:CHEF) to $84 from $79 previously and maintained a Buy rating. Benchmark said the quarter tracked in line with prior expectations and cited strong and highly visible underlying momentum in the business as support for the higher target.

The Chefs’ Warehouse, Inc. (NASDAQ:CHEF) distributes specialty food and center-of-the-plate products in the United States, the Middle East, and Canada.

1. Diebold Nixdorf, Incorporated (NYSE:DBD)

Potential upside: 21.09%

Number of Hedge Fund Holders: 26

On February 13, 2026, DA Davidson analyst Matt Summerville raised the price target on Diebold Nixdorf, Incorporated (NYSE:DBD) to $100 from $80 and maintained a Buy rating. Matt Summerville said the company continues to see healthy order entry and backlog, including nine new logos added within its expanding North America Retail platform.

Also on February 13, 2026, Wedbush raised its price target to $100 from $80 and kept an Outperform rating after strong Q4 results and 2026 guidance. Wedbush noted full-year EPS of $5.50 exceeded the $4.87 consensus estimate and said it is incrementally more positive following earnings, expecting 2025 momentum to carry into 2026, with the year in many ways mirroring last.

On February 12, 2026, Diebold Nixdorf, Incorporated (NYSE:DBD) reported Q4 non-GAAP EPS of $3.02 versus consensus of $1.65. CEO Octavio Marquez said, “2025 marked a defining year for Diebold Nixdorf,” highlighting revenue growth, adjusted EBITDA expansion, and more than doubling free cash flow. He added that the company is entering 2026 with momentum and financial flexibility to invest in growth, return capital, and drive long-term value.

Diebold Nixdorf, Incorporated (NYSE:DBD) provides automation and technology solutions for banking and retail customers globally and operates through its Banking and Retail segments.

While we acknowledge the potential of DBD to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than DBD and that has 100x upside potential, check out our report about this cheapest AI stock.

READ NEXT: 10 Most Profitable Undervalued Stocks to Buy and 11 Best Mining Stocks to Buy According to Wall Street

Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.